Cortex Pharmaceuticals, Inc. CORX Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2013 at 11:56 AM

Cortex Pharmaceuticals, Inc. CORX Company Overview

Stock Message Board http://investorshangout.com/search?q=CORX&...mp;yt1=Go!

Cortex Pharmaceuticals, Inc. CORX Current Price and Quotes
Last Price 0.0321
Previous Close 0.039 Open 0.032
Daily Range 0.0321 - 0.032 52wk Range 0.099 - 0.02
Volume 3,740 Dividend N/A
Average Vol (3m) 82,825 Yield N/A
Cortex Pharmaceuticals, Inc. CORX
Company Information

126 Valley Road
Suite C
Glen Rock, NJ 07452

Website: http://www.cortexpharm.com
Phone: 949-727-3157
Email: info@cortexpharm.com

Cortex Pharmaceuticals, Inc. CORX
Cortex Pharmaceuticals, Inc. CORX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2012 10-Q
CIK 0000849636
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Arnold S. Lippa President, CEO
Jeff E. Margolis Vice President, Treasurer, Secretary
Robert N. Weingarten Vice President, CFO
Company Directors

Arnold S. Lippa Chairman
Jeff E. Margolis
Service Providers

Auditor/Accountant
Haskell & White LLP
8001 Irvine Center Drive
Suite 300
Irvine, CA, 92618
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Cortex Pharmaceuticals, Inc. CORX
CORX Security Details

Share Structure

Market Value1 $4,623,734 a/o Sep 13, 2013
Shares Outstanding 144,041,558 a/o Aug 13, 2012
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders

Shareholders of Record 394 a/o Mar 30, 2012
Security Notes

Capital Change=shs decreased by 1 for 5 split. Ex-date=01-12-95. Rec date=01-12-95. Pay date=01-12-95
New Issue=7-89 3,300,000 shs in units (3 shs Com & 2 Class A Warr 7-17-94) at $6 per unit by D.H. Blair & Co., Inc.
Short Selling Data

Short Interest 346 (-0.57%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

American Stock Transfer & Trust Company

Cortex Pharmaceuticals, Inc. CORX Recent News

Cortex Pharmaceuticals, Inc. CORX Financials
Period Ending Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Total Revenue 3,115 10,474 - -
Cost of Revenue - - - -
Gross Profit 3,115 10,474 - -
Operating Expenses

Research and Development 2,188 3,739 4,598 10,780
Sales, General and Admin. 3,189 4,553 3,737 4,259
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,262) 2,182 (8,335) (15,039)
Income From Continuing Operations

Add'l Income/Expense Items - - (123) 443
Earnings Before Interest and Tax (2,255) 1,629 (8,441) (14,596)
Interest Expense - - - -
Earnings Before Tax (2,255) 1,629 (8,441) (14,596)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,255) 1,629 (8,441) (14,596)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,255) 1,629 (8,441) (14,596)
Preferred Stock and Other Adjustments - - (2,347) -
Net Income Applicable to Common Shareholders (2,255) 1,629 (10,788) (14,596)

CORX Cortex Pharmaceuticals, Inc. Research DD Guide

CORX Cortex Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=CORX&...mp;yt0=Go!
CORX Cortex Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/CORX/quote
CORX Cortex Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/CORX/chart
CORX Cortex Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/CORX/company-info
CORX Cortex Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/CORX/news
CORX Cortex Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/CORX/financials
CORX Cortex Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/CORX/filings
CORX Cortex Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/CORX/short-sales
CORX Cortex Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/CORX/insider-transactions
CORX Cortex Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/CORX/research
CORX Cortex Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=CORX
CORX Cortex Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=CORX+Historical+Prices
CORX Cortex Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=CORX
CORX Cortex Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=CORX+Basic+Chart
CORX Cortex Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CORX+Basic+Tech.+Analysis
CORX Cortex Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=CORX+Headlines
CORX Cortex Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=CORX+Press+Releases
CORX Cortex Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=CORX+Profile
CORX Cortex Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=CORX+Key+Statistics
CORX Cortex Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=CORX+Industry
CORX Cortex Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=CORX+Major+Holders
CORX Cortex Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=CORX+Insider+Transactions
CORX Cortex Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=CORX+Insider+Roster
CORX Cortex Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=CORX
CORX Cortex Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=CORX
CORX Cortex Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=CORX+Cash+Flow&annual
CORX Cortex Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/CORX
CORX Cortex Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/CORX
CORX Cortex Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/CORX:US
CORX Cortex Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=CORX
CORX Cortex Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=CORX
CORX Cortex Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/CORX
CORX Cortex Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=CORX
CORX Cortex Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/CORX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...